303 related articles for article (PubMed ID: 29361136)
1. Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma.
Ghorani E; Rosenthal R; McGranahan N; Reading JL; Lynch M; Peggs KS; Swanton C; Quezada SA
Ann Oncol; 2018 Jan; 29(1):271-279. PubMed ID: 29361136
[TBL] [Abstract][Full Text] [Related]
2. Influence of T Cell-Mediated Immune Surveillance on Somatic Mutation Occurrences in Melanoma.
Jiang C; Schaafsma E; Hong W; Zhao Y; Zhu K; Chao CC; Cheng C
Front Immunol; 2021; 12():703821. PubMed ID: 35111147
[TBL] [Abstract][Full Text] [Related]
3. Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma.
Qi YA; Maity TK; Cultraro CM; Misra V; Zhang X; Ade C; Gao S; Milewski D; Nguyen KD; Ebrahimabadi MH; Hanada KI; Khan J; Sahinalp C; Yang JC; Guha U
Mol Cell Proteomics; 2021; 20():100136. PubMed ID: 34391887
[TBL] [Abstract][Full Text] [Related]
4. MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design.
Cai W; Zhou D; Wu W; Tan WL; Wang J; Zhou C; Lou Y
BMC Genomics; 2018 Aug; 19(1):582. PubMed ID: 30075702
[TBL] [Abstract][Full Text] [Related]
5. pTuneos: prioritizing tumor neoantigens from next-generation sequencing data.
Zhou C; Wei Z; Zhang Z; Zhang B; Zhu C; Chen K; Chuai G; Qu S; Xie L; Gao Y; Liu Q
Genome Med; 2019 Oct; 11(1):67. PubMed ID: 31666118
[TBL] [Abstract][Full Text] [Related]
6. Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.
Roszik J; Haydu LE; Hess KR; Oba J; Joon AY; Siroy AE; Karpinets TV; Stingo FC; Baladandayuthapani V; Tetzlaff MT; Wargo JA; Chen K; Forget MA; Haymaker CL; Chen JQ; Meric-Bernstam F; Eterovic AK; Shaw KR; Mills GB; Gershenwald JE; Radvanyi LG; Hwu P; Futreal PA; Gibbons DL; Lazar AJ; Bernatchez C; Davies MA; Woodman SE
BMC Med; 2016 Oct; 14(1):168. PubMed ID: 27776519
[TBL] [Abstract][Full Text] [Related]
7. Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy.
Chowell D; Morris LGT; Grigg CM; Weber JK; Samstein RM; Makarov V; Kuo F; Kendall SM; Requena D; Riaz N; Greenbaum B; Carroll J; Garon E; Hyman DM; Zehir A; Solit D; Berger M; Zhou R; Rizvi NA; Chan TA
Science; 2018 Feb; 359(6375):582-587. PubMed ID: 29217585
[TBL] [Abstract][Full Text] [Related]
8. A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy.
Łuksza M; Riaz N; Makarov V; Balachandran VP; Hellmann MD; Solovyov A; Rizvi NA; Merghoub T; Levine AJ; Chan TA; Wolchok JD; Greenbaum BD
Nature; 2017 Nov; 551(7681):517-520. PubMed ID: 29132144
[TBL] [Abstract][Full Text] [Related]
9. Curatopes Melanoma: A Database of Predicted T-cell Epitopes from Overly Expressed Proteins in Metastatic Cutaneous Melanoma.
Lischer C; Eberhardt M; Jaitly T; Schinzel C; Schaft N; Dörrie J; Schuler G; Vera J
Cancer Res; 2019 Oct; 79(20):5452-5456. PubMed ID: 31416842
[TBL] [Abstract][Full Text] [Related]
10. Somatic mutational landscapes of adherens junctions and their functional consequences in cutaneous melanoma development.
Korla PK; Chen CC; Gracilla DE; Lai MT; Chen CM; Chen HY; Hwang T; Chen SY; Sheu JJ
Theranostics; 2020; 10(26):12026-12043. PubMed ID: 33204327
[TBL] [Abstract][Full Text] [Related]
11. Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy.
Restifo NP; Marincola FM; Kawakami Y; Taubenberger J; Yannelli JR; Rosenberg SA
J Natl Cancer Inst; 1996 Jan; 88(2):100-8. PubMed ID: 8537970
[TBL] [Abstract][Full Text] [Related]
12. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma.
Wu M; Wang Z; Zhang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569
[TBL] [Abstract][Full Text] [Related]
13. MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma.
Engelhard VH; Obeng RC; Cummings KL; Petroni GR; Ambakhutwala AL; Chianese-Bullock KA; Smith KT; Lulu A; Varhegyi N; Smolkin ME; Myers P; Mahoney KE; Shabanowitz J; Buettner N; Hall EH; Haden K; Cobbold M; Hunt DF; Weiss G; Gaughan E; Slingluff CL
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32385144
[TBL] [Abstract][Full Text] [Related]
14. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.
Liu X; Wang J
Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
Tian Q; Gao H; Zhao W; Zhou Y; Yang J
Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
[TBL] [Abstract][Full Text] [Related]
16. [Role of MHC class I molecules in anti-tumoral mechanisms in human malignant melanoma].
Dissemond J; Grabbe S
Hautarzt; 2006 Aug; 57(8):690-6. PubMed ID: 16163561
[TBL] [Abstract][Full Text] [Related]
17. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma.
Ohnmacht GA; Marincola FM
J Cell Physiol; 2000 Mar; 182(3):332-8. PubMed ID: 10653599
[TBL] [Abstract][Full Text] [Related]
19. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
20. Tools to define the melanoma-associated immunopeptidome.
Bräunlein E; Krackhardt AM
Immunology; 2017 Dec; 152(4):536-544. PubMed ID: 28755382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]